The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
LettersFull Access

Psychosis in a Patient With Silent Vascular Brain Lesions

To the Editor: A plethora of information is available on psychiatric disorders after vascular brain lesions presenting clinically as stroke, but there is scant literature on silent vascular brain lesions or infarcts without any overt neurological signs or symptoms presenting with psychiatric disorders. The extant literature on silent brain infarctions has focused mainly on depression and, to some extent, on mania, while psychosis in this context has only been rarely described.1,2 We describe a case of psychosis in a patient with silent vascular lesions in the right frontal lobe and discuss the interplay of cognitive deficits and psychiatric presentation in such cases.

Case Report

A 69-year-old white man was transferred from the intensive care unit, where he was being treated for possible delirium tremens, to the psychiatric unit, for persistent depressive and psychotic symptoms. He had a longstanding history of alcohol use. He also had type 2 diabetes mellitus, dyslipidemia, and coronary artery disease, and had an implantable cardioverter defibrillator. During his index presentation, the patient endorsed delusions that his wife was having an affair with a neighbor and had persecutory delusions regarding this person. His depressive symptoms included sad mood, loss of interest, easy fatigability, trouble staying asleep, and decreased energy. The psychotic symptoms had started about 3 years ago, whereas the depressive symptoms had been present for the past 3 months. The patient scored 18/30 on the Montreal Cognitive Assessment, with impairment in visuospatial/executive skills, attention, verbal fluency, and delayed recall.3 He scored 11/18 on the Frontal Assessment Battery, with impairment in conceptualization, lexical fluency, programming, and inhibitory (Go/No-Go) domains.4 His blood counts, electrolytes, renal function tests, TSH, B12, and folic acid were normal. Urine analysis and urine drug screen were non-contributory. Neurologic examination was unremarkable. Abnormal laboratory parameters included fasting glucose (128 mg/dl), alanine aminotransferase (82 units/liter), and aspartate aminotransferase (81 units/liter). Head CT scan showed an area of encephalomalacia (1.3 cm x 2.2 cm) in the anterior and lateral aspect of the right frontal lobe. There were scattered low-attenuation foci in the external capsule bilaterally, left more than right. The head CT results did not differ from another study done about 3 years ago (done after the patient had a fall), but neither the patient nor his family were aware of the results of the previous head CT. However, the family did corroborate the onset of the patient's psychotic symptoms approximately to the time of the first head CT study. Although the patient was started on quetiapine for psychotic symptoms at that time, the late-onset psychotic symptoms were not correlated with the head CT findings. The patient and his family denied that the patient was ever treated for stroke or had any overt neurological symptoms in the past. The patient was diagnosed with Vascular Dementia with Delusions and Depressed Mood, and Alcohol Dependence, according to DSM-IV-TR criteria. During his present admission, the patient was treated with sertraline (150 mg/day) and quetiapine (100 mg/day), with improvement in both depressive and psychotic symptoms. He did not consent to a trial of donepezil.

Discussion

A silent cerebral infarction can present with one of the four psychiatric symptom clusters: affective, paranoid delusional, confusional state, and changes in mood with behavioral disturbance.5 However, without a high index of suspicion, these silent vascular brain lesions are like1y to be missed in patients presenting with prototypical psychiatric syndromes. In our patient, besides the vascular brain changes, chronic alcohol use, comorbid depression, and, possibly, vascular dementia itself may have contributed to the presentation. Right-side brain lesions are more common in patients who develop psychosis after stroke.68 The role of frontal lobe deficits in this patient also deserves mention. Delusions in patients with dementia are associated with frontal lobe changes,9 and patients with psychotic depression demonstrate fronto-temporal atrophy and also do poorly on frontal-lobe tests, as compared with nonpsychotic patients.10 Thus, clinicians should explore for underlying silent vascular brain lesions, especially in older patients with psychosis and frontal lobe/executive function deficits. Whereas vascular depression and mania have operational definitions, more research is needed on “vascular psychosis” in this respect.11,12 It would be interesting to elucidate whether vascular psychosis is an independent entity or exists on a continuum comprising vascular depression and vascular dementia, considering a report of the progression of vascular depression to vascular dementia in a patient with silent vascular brain lesions.13

Mental Health BranchHumboldt County Dept. of Health and Human ServicesEureka, CAUnited Indian Health Services Arcata, CA
Correspondence:
References

1. Fujikawa T , Yamawaki S , Touhouda Y : Incidence of silent cerebral infarction in patients with major depression. Stroke 1993; 24:1631–1634Crossref, MedlineGoogle Scholar

2. Fujikawa T , Yamawaki S , Touhouda Y : Silent cerebral infarctions in patients with late-onset mania. Stroke 1995; 26:946–949Crossref, MedlineGoogle Scholar

3. Nasreddine ZS , Phillips NA , Bédirian V, et al.: The Montreal Cognitive Assessment (MoCA): a brief screening tool for mild cognitive impairment J Am Geriatr Soc 2005; 53:695–699Crossref, MedlineGoogle Scholar

4. Dubois B , Slachesvsky A , Litvan I, et al.: The FAB: a frontal assessment battery at bedside. Neurology 2000; 55:1621–1626Crossref, MedlineGoogle Scholar

5. Nagaratnam N , Pathma-Nathan N : Behavioral and psychiatric aspects of silent cerebral infarction. Br J Clin Pract 1997; 51:160–163MedlineGoogle Scholar

6. Berthier M , Starkstein S : Acute atypical psychosis following a right-hemisphere stroke. Acta Neurol Belg 1987; 87:125–131MedlineGoogle Scholar

7. Price BH , Mesulam M : Psychiatric manifestations of right-hemisphere infarctions. J Nerv Ment Dis 1985; 173:610–614Crossref, MedlineGoogle Scholar

8. Rabins PV , Starkstein SE , Robinson RG : Risk factors for developing atypical (schizophreniform) psychosis following stroke. J Neuropsychiatry Clin Neurosci 1991; 3:6–9LinkGoogle Scholar

9. Binetti G , Padovani A , Magni E, et al.: Delusions and dementia: clinical and CT correlates. Acta Neurol Scand 1995; 91:271–275Crossref, MedlineGoogle Scholar

10. Simpson S , Baldwin RC , Jackson A, et al.: The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features. Biol Psychiatry 1999; 45:193–204Crossref, MedlineGoogle Scholar

11. Alexopoulos GS , Meyers BS , Young RC, et al.: ‘Vascular depression’ hypothesis. Arch Gen Psychiatry 1997; 54:915–922Crossref, MedlineGoogle Scholar

12. Wijeratne C , Malhi GS : Vascular mania: an old concept in danger of sclerosing? a clinical overview. Acta Psychiatr Scand 2007; 116(suppl. 434):35–40CrossrefGoogle Scholar

13. Loganathan S , Phutane VH , Prakash O, et al.: Psychosis in a patient with silent vascular brain lesions. J Neuropsychiatry Clin Neurosci 2010; 22:451 e34–e35Crossref, MedlineGoogle Scholar